Articles

Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia

Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany;International Graduate School of Molecular Medicine, Ulm University, Ulm, Germany
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany;International Graduate School of Molecular Medicine, Ulm University, Ulm, Germany;PhD Program in Biosciences, University of Padova, Padova, Italy
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
Department of Obstetrics and Gynecology, Ulm University Medical Center, Ulm, Germany
Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany
Department of Pediatrics, Charité Center Gynecology, Perinatal, Pediatric and Adolescent Medicine, Berlin, Germany
Department of General Pediatrics, Hematology and Oncology, Children’s University Hospital Tübingen, Tübingen, Germany
Department of General Pediatrics, Hematology and Oncology, Children’s University Hospital Tübingen, Tübingen, Germany
Department of Women’s and Children’s Health, University of Padova, Padova, Italy
Department of Obstetrics and Gynecology, Ulm University Medical Center, Ulm, Germany
Department of Internal Medicine III, Ulm University Medical Center, Ulm, Germany
Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
Vol. 105 No. 1 (2020): January, 2020 https://doi.org/10.3324/haematol.2018.199364